openPR Logo
Press release

France Animal Vaccine Market Industry Growth, Size, Share and Forecast 2019-2025 | Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, and Vetoquinol S.A.

01-14-2020 10:41 AM CET | Health & Medicine

Press release from: Orion Market Research

France Animal Vaccine Market

France Animal Vaccine Market

France animal vaccine market is estimated to grow at a CAGR of around 5.6% during the forecast period. France is well known for the high yielding dairy goats and a major producer of dairy products, including cheese. Additionally, France is also a substantial producer of meat across the region. France is breeding a few dairy breeds of goats including Saanen, Toggenburg, Alpine, and Anglo-Nubian, which are widespread and are frequently found in commercial herds throughout the country. Exotic breeds of the goat are increasing proportionally owing to the emerging goat exports from France. As the breeding of goats is increasing year-over-year, consumption of animal vaccines is also growing in the country. Vaccines are becoming an integral part of the animal husbandry across the country due to stringent government regulations imposed by the EU, which in turn, is leading to propel the market growth.

Get Sample Copy of France Animal Vaccine Market at: https://www.omrglobal.com/request-sample/france-animal-vaccine-market

Key players in the France animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, and Vetoquinol S.A.

These players are adopting crucial strategies, such as mergers and acquisitions, product launches, geographical expansion, and partnerships and collaborations to maintain their competitiveness and increase their market share. For instance, in September 2019, Boehringer Ingelheim declared that it is developing one of the major biotechnology manufacturing sites for veterinary vaccines in Europe, setting up on pioneering expertise of France in veterinary public health.

For More Information get A full report of France Animal Vaccine is available at: https://www.omrglobal.com/industry-reports/france-animal-vaccine-market

This investment of over $224 million will significantly enhance manufacturing capacities for antigens and vaccines to fight against highly contagious diseases. This will enable to offer the means to fight against epidemics of diseases among animals, including bluetongue and foot-and-mouth disease. Through this investment, the Lyon metropolitan area will reinforce its position in the European vaccine valley. With this expansion, the company will be able to supply millions of doses in a few days from Lyon for ring vaccination in affected areas which will support to stop the disease progression.

France Animal Vaccine Market Segmentation

France Animal Vaccine Market by Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other Animal Vaccines

France Animal Vaccine Market by Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/france-animal-vaccine-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release France Animal Vaccine Market Industry Growth, Size, Share and Forecast 2019-2025 | Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, and Vetoquinol S.A. here

News-ID: 1895538 • Views:

More Releases from Orion Market Research

Anti-Viral Drug Market - Industry Trends and Forecast to 2033
Anti-Viral Drug Market - Industry Trends and Forecast to 2033
The global antiviral drugs market is projected to grow from USD 50 billion in 2023 to USD 71 billion by 2033, with a compound annual growth rate (CAGR) of 3.73% during the forecast period from 2024 to 2033. Anti-Viral Drug Market Overview Antiviral drugs are essential in the treatment and prevention of viral infections, including HIV, hepatitis, influenza, and emerging viral diseases. The market's growth is driven by the increasing
Tuberculosis Vaccine Market - Industry Trends and Forecast to 2032
Tuberculosis Vaccine Market - Industry Trends and Forecast to 2032
The global tuberculosis (TB) vaccine market was valued at approximately USD 63.11 billion in 2023 and is projected to reach USD 88.28 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.38% from 2024 to 2032. Tuberculosis Vaccine Market Overview The tuberculosis vaccine market is primarily driven by the Bacillus Calmette-Guérin (BCG) vaccine, which has been the standard preventive measure against TB for decades. Despite its widespread use,
Favipiravir Market: Emerging Trends and Growth Forecast to 2032
Favipiravir Market: Emerging Trends and Growth Forecast to 2032
The global Favipiravir market was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2032. Favipiravir Market Overview Favipiravir, an antiviral medication initially developed for influenza, gained prominence during the COVID-19 pandemic due to its potential efficacy against the virus. The market's growth is driven by the increasing prevalence
Beauty Tools Market Overview: Growth, Share, Value, Size, and Scope
Beauty Tools Market Overview: Growth, Share, Value, Size, and Scope
The global beauty tools market was valued at approximately USD 68.9 billion in 2023 and is projected to reach USD 99.78 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2032. Beauty Tools Market Overview The beauty tools market encompasses a wide range of products, including hair care tools, razors, trimmers, brushes, combs, and manicure and pedicure tools. The market's growth is driven by

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the